References
[1] Sadosty AT, Boie ET, Stead LG. Pulmonary embolism. Emerg Med Clin
North Am 2003;21:363–84.
[2] Goldhaber SZ. Pulmonary embolism. Lancet 2004;363:1295–305.
[3] Layish DT, Tapson VF. Pharmacologic hemodynamic support in massive
pulmonary embolism. Chest 1997;111:218–24.
[4] Vasan RS. Biomarkers of cardiovascular disease: molecular basis and prac-
tical considerations. Circulation 2006;113:2335–62.
[5] Goldhaber SZ. Cardiac biomarkers in pulmonary embolism. Chest 2003;123:
1782–4.
[6] Harrison A, Amundson S. Evaluation and management of the acutely
dyspneic patient: the role of biomarkers. Am J Emerg Med 2005;23:
371–8.
[7] Meyer T, Binder L, Hruska N, Luthe H, Buchwald AB. Cardiac troponin I
elevation in acute pulmonary embolism is associated with right ventricular
dysfunction. J Am Coll Cardiol 2000;36:1632–6.
[8] Pruszczyk P, Bochowicz A, Torbicki A, et al. Cardiac troponin T mon-
itoring identifies high-risk group of normotensive patients with acute
pulmonary embolism. Chest 2003;123:1947–52.
[9] Konstantinides S, Geibel A, Olschewski M, et al. Importance of cardiac
troponins I and T in risk stratification of patients with acute pulmonary
embolism. Circulation 2002;106:1263–8.
[10] Douketis JD, Crowther MA, Stanton EB, Ginsberg JS. Elevated cardiac
troponin concentrations in patients with submassive pulmonary embolism.
Arch Intern Med 2002;162:79–81.
[11] Douketis JD, Leeuwenkamp O, Grobara P, et al. The incidence and
prognostic significance of elevated cardiac troponins in patients with
submassive pulmonary embolism. J Thromb Haemost 2005;3:508–13.
[12] Horlander KT, Leeper KV. Troponin concentrations as a guide to treatment
of pulmonary embolism. Curr Opin Pulm Med 2003;9:374–7.
[13] Frisdal E, Gest V, Vieillard-Baron A, et al. Gelatinase expression in pul-
monary arteries during experimental pulmonary hypertension. Eur Respir J
2001;18:838–45.
[14] Palei ACT, Zaneti RAG, Fortuna GM, Gerlach RF, Tanus-Santos JE.
Hemodynamic benefits of matrix metalloproteinase-9 inhibition by
doxycycline during experimental acute pulmonary embolism. Angiology
2005;5:611–7.
[15] Souza-Costa DC, Zerbini T, Palei AC, Gerlach RF, Tanus-Santos JE. L-
arginine attenuates acute pulmonary embolism-induced increases in lung
matrix metalloproteinase-2 and matrix metalloproteinase-9. Chest 2005;128:
3705–10.
[16] Fortuna GM, Figueiredo-Lopes L, Dias-Junior CAC, Gerlach RF, Tanus-
Santos JE. A role for matrix metalloproteinase-9 in the hemodynamic
changes following acute pulmonary embolism. Int J Cardiol 2007;114:
22–7.
[17] Souza-Costa DC, Figueiredo-Lopes L, Alves-Filho JC, et al. Protective
effects of atorvastatin in rat models of acute pulmonary embolism:
involvement of matrix metalloproteinase-9. Crit Care Med 2007;35:
239–45.
[18] Dias-Junior CA, Gladwin MT, Tanus-Santos JE. Low-dose intravenous
nitrite improves hemodynamics in a canine model of acute pulmonary
thromboembolism. Free Radic Biol Med 2006;41:1764–70.
[19] Dias-Junior CA, Tanus-Santos JE. Hemodynamic effects of sildenafil
interaction with a nitric oxide donor compound in a dog model of acute
pulmonary embolism. Life Sci 2006;79:469–74.
[20] Dias-Junior CA, Vieira TF, Moreno Jr H, Evora PR, Tanus-Santos JE.
Sildenafil selectively inhibits acute pulmonary embolism-induced pul-
monary hypertension. Pulm Pharmacol Ther 2005;18:181–6.
[21] Dias-Junior CA, Souza-Costa DC, Zerbini T, Rocha JBT, Gerlach RF,
Tanus-Santos JE. Effect of sildenafil on pulmonary embolism-induced
oxidative stress and pulmonary hypertension. Anesth Analg 2005;101:
115–20.
[22] Souza-Tarla CD, Uzuelli JA, Machado AA, Gerlach RF, Tanus-Santos JE.
Methodological issues affecting the determination of plasma matrix
metalloproteinase (MMP)-2 and MMP-9 activities. Clin Biochem 2005;38:
410–
4.
[23] Gerlach RF, Uzuelli JA, Souza-Tarla CD, Tanus-Santos JE. Effect of
anticoagulants on the determination of plasma matrix metalloproteinase
(MMP)-2 and MMP-9 activities. Anal Biochem 2005;344:147–9.
[24] Gerlach RF, Demacq C, Jung K, Tanus-Santos JE. Rapid separation of
serum does not avoid artificially higher matrix metalloproteinase (MMP)-9
concentrations in serum versus plasma. Clin Biochem 2007;40:119–23.
[25] Punukollu G, Khan IA, Gowda RM, Lakhanpal G, Vasavada BC, Sacchi
TJ. Cardiac troponin I release in acute pulmonary embolism in relation to
the duration of symptoms. Int J Cardiol 2005;99:207–11.
[26] Kucher N, Goldhaber SZ. Cardiac biomarkers for risk stratification of
patients with acute pulmonary embolism. Circulation 2003;108:2191–4.
[27] Muller-Bardorff M, Weidtmann B, Giannitsis E, Kurowski V, Katus HA.
Release kinetics of cardiac troponin T in survivors of confirmed severe
pulmonary embolism. Clin Chem 2002;48:673–5.
[28] Pacouret G, Schellenberg F, Hamel E, Charbonnier B, Mouray H.
Troponin I in massive acute pulmonary embolism: results of a prospective
series. Presse Med 1998;27:1627.
[29] Kerbaul F, Gariboldi V, Giorgi R, et al. Effects of levosimendan on acute
pulmonary embolism-induced right ventricular failure
⁎
. Crit Care Med
2007; Jun 12; (Electronic publication ahead of print).
[30] Souza-Costa DC, Zerbini T, Metzger IF, Rocha JB, Gerlach RF, Tanus-
Santos JE. l-Arginine attenuates acute pulmonary embolism-induced
oxidative stress and pulmonary hypertension. Nitric Oxide 2005;12:9–14.
[31] Tanus-Santos JE, Gordo WM, Udelsmann A, Cittadino MH, Moreno Jr H.
Nonselective endothelin-receptor antagonism attenuates hemodynamic
changes after massive pulmonary air embolism in dogs. Chest 2000;118:
175–9.
[32] Eagleton MJ, Henke PK, Luke CE, et al. Inflammation and intimal hy-
perplasia associated with experimental pulmonary embolism. J Vasc Surg
2002;36:581–8.
[33] Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA, Opdenakker
G. Biochemistry and molecular biology of gelatinase B or matrix
metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol 2002;37:
375–536.
5J.A. Uzuelli et al. / Clinica Chimica Acta xx (2007) xxx–xxx
ARTICLE IN PRESS
Please cite this article as: Uzuelli JA, et al, Severity dependent increases in circulating cardiac troponin I and MMP-9 concentrations after experimental acute
pulmonary thromboembolism, Clin Chim Acta (2007), doi:10.1016/j.cca.2007.11.001